Rocket Pharmaceuticals (RCKT) Current Leases (2019 - 2025)
Historic Current Leases for Rocket Pharmaceuticals (RCKT) over the last 7 years, with Q3 2025 value amounting to $1.9 million.
- Rocket Pharmaceuticals' Current Leases rose 298.59% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 298.59%. This contributed to the annual value of $1.9 million for FY2024, which is 362.93% up from last year.
- Rocket Pharmaceuticals' Current Leases amounted to $1.9 million in Q3 2025, which was up 298.59% from $1.9 million recorded in Q2 2025.
- Rocket Pharmaceuticals' 5-year Current Leases high stood at $1.9 million for Q3 2025, and its period low was $1.7 million during Q1 2021.
- In the last 5 years, Rocket Pharmaceuticals' Current Leases had a median value of $1.8 million in 2023 and averaged $1.8 million.
- Data for Rocket Pharmaceuticals' Current Leases shows a peak YoY increase of 1197.56% (in 2021) and a maximum YoY decrease of 273.72% (in 2021) over the last 5 years.
- Quarter analysis of 5 years shows Rocket Pharmaceuticals' Current Leases stood at $1.7 million in 2021, then grew by 2.78% to $1.7 million in 2022, then grew by 3.17% to $1.8 million in 2023, then grew by 3.63% to $1.9 million in 2024, then grew by 2.21% to $1.9 million in 2025.
- Its last three reported values are $1.9 million in Q3 2025, $1.9 million for Q2 2025, and $1.9 million during Q1 2025.